Compound Summary
Compound Name: | 5-Fluoro-2'-deoxyuridine |
Compound CID: | 3363 |
Synonyms: | "5-Fluoro-2-deoxyuridine 2968-28-7 Floxuridin FdUrd 5-fluoro-1-4-hydroxy-5-(hydroxymethyl)oxolan-2-ylpyrimidine-2,4-dione More... |
Iupac Name: | 5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
InChI: | InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16) |
InChIKey: | ODKNJVUHOIMIIZ-UHFFFAOYSA-N |
Canonical Smiles: | C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O |
Isomeric Smiles: | C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O |
Molecular Weight: | 246.19 |
Molecular Formula: | C9H11FN2O5 |
Molecular Weight: | 246.19 |
Molecular Formula: | C9H11FN2O5 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 17 |
Complexity: | 386 |
5-Fluoro-2'-deoxyuridine | 5-Fluoro-2'-deoxyuridine |
---|---|
"5-Fluoro-2-deoxyuridine |
2968-28-7 |
Floxuridin |
FdUrd |
5-fluoro-1-4-hydroxy-5-(hydroxymethyl)oxolan-2-ylpyrimidine-2,4-dione |
5-fluoro-1-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione |
Uridine, 2-deoxy-5-fluoro- |
5-FUDR |
5-Fluorouracil deoxyriboside |
FDUR |
NSC 27640 |
5-fluoro-1-4-hydroxy-5-(hydroxymethyl)-2-oxolanylpyrimidine-2,4-dione |
Ro 5-0360 |
Uridine, 2-deoxy-5-fluoro" |
Uridine, 2-deoxy-5-fluoro- |
NSC27640 |
955-24-8 |
ACMC-209kqz |
Neuro_000015 |
CHEMBL6628 |
NCIOpen2_002917 |
SCHEMBL2050487 |
CHEBI:94445 |
DTXSID70274397 |
.beta.-5-Fluoro-2-deoxyuridine |
HMS3259B07 |
HMS3371D03 |
HMS3654N13 |
ALBB-023675 |
NSC66259 |
NSC-66259 |
NSC527320 |
AKOS015998165 |
MCULE-4401224773 |
NC00623 |
NSC-527320 |
NCGC00018095-02 |
NCGC00018095-03 |
NCGC00018095-04 |
NCGC00094992-01 |
NCGC00094992-02 |
NCGC00094992-03 |
LS-07473 |
NCI60_002251 |
DB-020996 |
WLN: T6NVMVJ EF A- ET5OTJ B1Q CQ |
FT-0620392 |
EN300-50293 |
1.beta.-D-2-Deoxyribofuranosyl-5-flurouracil" |
1.beta.-D-2-Deoxyribofuranosyl-5-fluorouracil |
AB01273927-01 |
179671-EP2270006A1 |
179671-EP2277861A1 |
1-(2-Deoxy-.beta.-D-ribofuranosyl)-5-fluorouracil |
1-(2-Deoxy-b-D-threo-pentofuranosyl)-5-fluorouracil |
BRD-A80638690-001-01-0 |
Q27166311 |
5-Fluor-1-(.beta.-2-deoxyribofuranosyl)pyrimidin-2,4(1H,3H)-dion" |
(2S,3S)-2-(3-Hydroxypyrrolidin-1-yl)-1-phenylethylmethylcarbamicacidbenzylester |
1397179-21-3 |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 100 | ug/mL | S | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 100 | ug/mL | NS | N2 | 33683565 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 1 | 2 |